Search

Meet BIOXYTOL, our new member. We talked its with Kamaljit S. Sood, CEO.

Meet THYTECH, our new member. We talked to its Rafael Correa-Rocha, Director & Co-Founder.

The event will feature a brief review of the topline results of the Phase IIb PORTICO study, then a discussion with experts.

The technical meeting and collaborative forum have been held under the title "Applications of non-viral vectors in gene editing and therapy: Challenges for academia and industry."

This initiative aims to have a positive long term impact on the environment, economy and society by helping achieve 10 of the Sustainable Development Goals (SDG).

January 10th, in an event with numerous institutional representatives, headed by the Lehendakari Iñigo Urkullu, together with representatives from the business, financial, scientific-technological and

The Investor Day, organized by AseBio and positioned as the benchmark meeting between investors and Spanish biotech companies, will take place on May 15th.

Innovation has enabled breakthroughs such as recent drugs for Alzheimer's disease, the use of devices that stimulate brain function for the treatment of certain pathologies or Virtual Reality for post